Skip to main content

Radiofrequency Ablation Systems and Operating Mechanisms

  • Chapter
  • First Online:
Radiofrequency Ablation for Small Hepatocellular Carcinoma

Abstract

In the past two decades, local ablative technique has become an important therapeutic approach for small hepatocellular carcinoma (HCC). In those various therapies, radiofrequency ablation (RFA) has attracted the greatest interest from surgeons due to its satisfactory effectiveness and safety in management of HCC (lesion ≤5.0 cm in diameter). RFA now is regarded as a curative therapy for HCC, liver resection as well as liver transplantation [1–3].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Llovet JM, Bruix J. Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol. 2008;48 Suppl 1:S20–37.

    Article  CAS  PubMed  Google Scholar 

  2. Kudo M, Izumi N, Kokudo N, Matsui O, Sakamoto M, et al. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. Dig Dis. 2010;2011(29):339–64.

    Google Scholar 

  3. Lau WY, Leung TW, Yu SC, et al. Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future. Ann Surg. 2003;237:171–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Peng Z-W, Liang H-H, Chen M-S, Zhang Y-J, Li P, Pang X-H, Li J-Q, Zhang Y-Q, Lau WY. Percutaneous radiofrequency ablation for the treatment of hepatocellular carcinomas in the caudate lobe. Eur J Surg Oncol. 2008;34(2):166–72.

    Article  PubMed  Google Scholar 

  5. Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg. 2006;243(3):321–8.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Buscarini L, Buscarini E, Di Stasi M, et al. Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results. Eur Radiol. 2001;11(6):914–21.

    Article  CAS  PubMed  Google Scholar 

  7. Lencioni R, Crocetti L, Cioni D, et al. Percutaneous radiofrequency ablation of hepatic colorectal metastases. Technique, indications, results, and new promises. Invest Radiol. 2004;39:689–97.

    Article  PubMed  Google Scholar 

  8. Rossi S, Di Stasi M, Buscarini E. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer [J]. AJR Am J Roentgenol. 1996;167(3):759–68.

    Article  CAS  PubMed  Google Scholar 

  9. Peng Z-W, Zhang Y-J, Chen M-S, Liang H-H, Li J-Q, Zhang Y-Q, Lau WY. Risk factors of survival after percutaneous radiofrequency ablation of hepatocellular carcinoma. Surg Oncol. 2008;17:23–31.

    Article  PubMed  Google Scholar 

  10. Livraghi T, Lazzaroni S, Meloni F. Radiofrequency ablation of hepatocellular carcinoma [J]. Eur J Ultrasound. 2001;13(2):159–66.

    Article  CAS  PubMed  Google Scholar 

  11. Brieger J, Pereira PL, Trübenbach J, Schenk M, Kröber SM, Schmidt D, Aubé C, Claussen CD, Schick F. In vivo efficiency of four commercial monopolar radiofrequency ablation systems: a comparative experimental study in pig liver. Invest Radiol. 2003;38(10):609–16.

    Article  PubMed  Google Scholar 

  12. Schmidt D, Trübenbach J, Brieger J, Koenig C, Putzhammer H, Duda SH, Claussen CD, Pereira PL. Automated saline-enhanced radiofrequency thermal ablation: initial results in ex vivo bovine livers. AJR Am J Roentgenol. 2003;180(1):163–5.

    Article  PubMed  Google Scholar 

  13. Pereira PL, Trübenbach J, Schenk M, Subke J, Kroeber S, Schaefer I, Remy CT, Schmidt D, Brieger J, Claussen CD. Radiofrequency ablation: in vivo comparison of four commercially available devices in pig livers. Radiology. 2004;232(2):482–90.

    Article  PubMed  Google Scholar 

  14. Brace C. Thermal tumor ablation in clinical use. IEEE Pulse. 2011;2(5):28–38.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Livraghi T, Solbiati L, Meloni MF, et al. Treatment of liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study [J]. Radiology. 2003;226(2):441–51.

    Article  PubMed  Google Scholar 

  16. Zhang YJ, Liang HH, Chen MS, et al. Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randomized trial. Radiology. 2007;244:599–607.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yaojun Zhang MD, PhD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Zhang, Y. (2016). Radiofrequency Ablation Systems and Operating Mechanisms. In: Chen, M., Zhang, Y., Lau, W. (eds) Radiofrequency Ablation for Small Hepatocellular Carcinoma. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-7258-7_3

Download citation

  • DOI: https://doi.org/10.1007/978-94-017-7258-7_3

  • Published:

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-017-7257-0

  • Online ISBN: 978-94-017-7258-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics